Jun Lei
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Ubiquitin and proteasome pathways 5
- Wnt/β-catenin signaling in development and cancer 4
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 3
-
- Gallbladder and Bile Duct Disorders 5
- Co-authors
- Jianghua Shao (10 shared papers)Rongfa Yuan (11 shared papers)Xiuxia Liu (6 shared papers)Linquan Wu (7 shared papers)Ge Jin (7 shared papers)Xin Yu (4 shared papers)Yan Chen (2 shared papers)Junwen Hu (2 shared papers)
- Journals
- Surgical Endoscopy (4 papers)Medicine (2 papers)Oncotarget (2 papers)BMC Surgery (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jun Lei
50 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 95
- Hepatology 131
- Cancer Research 203
- Oncology 187
- Pulmonary and Respiratory Medicine 191
- Molecular Biology 415
Countries citing papers authored by Jun Lei
This map shows the geographic impact of Jun Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Lei more than expected).
Fields of papers citing papers by Jun Lei
This network shows the impact of papers produced by Jun Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Lei. The network helps show where Jun Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 102 | |
| 2 | 2016 | 63 | |
| 3 | 2016 | 59 | |
| 4 | 2009 | 50 | |
| 5 | 2017 | 41 | |
| 6 | 2015 | 40 | |
| 7 | 2015 | 39 | |
| 8 | 2018 | 39 | |
| 9 | 2019 | 32 | |
| 10 | 2017 | 32 | |
| 11 | 2016 | 31 | |
| 12 | 2019 | 30 | |
| 13 | 2020 | 27 | |
| 14 | HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II. | 2018 | 27 |
| 15 | 2018 | 25 | |
| 16 | 2015 | 24 | |
| 17 | 2018 | 23 | |
| 18 | 2022 | 22 | |
| 19 | 2020 | 21 | |
| 20 | 2019 | 20 |
About Jun Lei
Jun Lei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Hepatology, having authored 51 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers), Gallbladder and Bile Duct Disorders (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Cancer-related gene regulation (4 papers), Hepatitis B Virus Studies (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hepatology (131 citations), Cancer Research (203 citations), Oncology (187 citations), Pulmonary and Respiratory Medicine (191 citations) and Molecular Biology (415 citations). Jun Lei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jianghua Shao, Rongfa Yuan, Xiuxia Liu, Linquan Wu, Ge Jin, Xin Yu, Yan Chen, Junwen Hu, Wenxiong Zhang and Ming Li. Their work appears in journals such as Surgical Endoscopy, Medicine, Oncotarget, BMC Surgery and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.